| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.25▲ | 2.24▲ | 2.22▲ | 2.21▲ | 2.39▼ |
| MA10 | 2.26▼ | 2.23▲ | 2.21▲ | 2.29▼ | 3.43▼ |
| MA20 | 2.24▲ | 2.21▲ | 2.21▲ | 2.52▼ | 5.07▼ |
| MA50 | 2.22▲ | 2.30▼ | 2.30▼ | 4.07▼ | 3.59▼ |
| MA100 | 2.31▼ | 2.39▼ | 2.99▼ | 5.38▼ | 9.59▼ |
| MA200 | 2.48▼ | 3.74▼ | 4.15▼ | 3.81▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.012▲ | 0.018▲ | 0.067▲ | -0.464▼ |
| RSI | 51.838▲ | 51.699▲ | 49.614▼ | 39.677▼ | 36.100▼ |
| STOCH | 57.275 | 62.321 | 61.979 | 25.924 | 2.313▼ |
| WILL %R | -38.889 | -21.875▲ | -19.444▲ | -66.028 | -97.166▼ |
| CCI | 13.018 | 86.897 | 89.076 | -49.482 | -101.910▼ |
|
Sunday, January 18, 2026 01:29 AM
Biodexa Pharmaceuticals PLC ADR research and ratings by Barron's. View BDRX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
|
|
Thursday, January 15, 2026 08:39 AM
The FDA clears Becton Dickinson's EnCor EnCompass breast biopsy system, with a U.S. launch planned for early 2026.
|
|
Thursday, January 15, 2026 06:02 AM
BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue removal system.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/01/26 | 2.255 | 2.255 | 2.255 | 2.255 | 89,464 |
| 16/01/26 | 2.24 | 2.29 | 2.10 | 2.24 | 1,199,445 |
| 15/01/26 | 2.17 | 2.25 | 2.09 | 2.17 | 109,440 |
| 14/01/26 | 2.15 | 2.249 | 2.06 | 2.09 | 125,600 |
| 13/01/26 | 2.31 | 2.37 | 2.25 | 2.29 | 111,400 |
| 12/01/26 | 2.35 | 2.352 | 2.26 | 2.33 | 79,000 |
| 09/01/26 | 2.39 | 2.454 | 2.28 | 2.35 | 122,800 |
| 08/01/26 | 2.30 | 2.36 | 2.23 | 2.31 | 97,500 |
| 07/01/26 | 2.41 | 2.469 | 2.29 | 2.42 | 101,100 |
| 06/01/26 | 2.47 | 2.51 | 2.39 | 2.45 | 58,000 |
|
|
||||
|
|
||||
|
|